-
Awarded19/03/2025
-
Today17/04/2025
Utilities
- indicates text translated automatically in your browsing language
Award of the Specific Contract derived from the Dynamic System of Acquisition of the Supply of the Exclusive Medicine FOSLEVODOPA/FOSCARBIDOPA 240 MG/ML + 12 MG/ML INYECTABLE PERFUSION 10 ML VIAL for the Integral Sanitari Consortium Text automatically translated in your browsing language Automatically translated
Award of the Specific Contract of the Consorci Sanitari Integral derived from the Dynamic System of Acquisition of the Supply of the Exclusive Medicine FOSLEVODOPA/FOSCARBIDOPA 240 MG/ML + 12 MG/ML INYECTABLE PERFUSION 10 ML VIAL processed by the Consorci de Salut i dāAtenció Social de Catalunya Text automatically translated in your browsing language Automatically translated
Type: price
Description: SegĆŗn los criterios detallados en los pliegos de la licitación del contrato especĆfico (ver PCAP)
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.